Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
engaging the pd 1 pathway in systemic sclerosis attenuates inflammation driven fibrosis
Original title: “Engaging the PD-1 pathway in systemic sclerosis attenuates inflammation-driven fibrosis.”
impact of hydroxychloroquine on mortality and cardiovascular outcomes in systemic sclerosis a retrospective cohort study
Original title: “Impact of Hydroxychloroquine on Mortality and Cardiovascular Outcomes in Systemic Sclerosis: A Retrospective Cohort Study.”